Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 3:37 PM EDT

43.90

-0.18 (-0.42%)

Volume

12,185,478

52 week range

40.94 - 61.71

Open43.81
Day High44.33
Day Low43.67
Prev Close44.08
52 Week High61.71
52 Week High Date12/20/21
52 Week Low40.94
52 Week Low Date10/13/21

Key Stats

Market Cap246.354B
Shares Out5.612B
10 Day Average Volume18.05M
Dividend1.60
Dividend Yield3.65%
Beta0.68
YTD % Change-25.78

KEY STATS

Open43.81
Day High44.33
Day Low43.67
Prev Close44.08
52 Week High61.71
52 Week High Date12/20/21
52 Week Low40.94
52 Week Low Date10/13/21
Market Cap246.354B
Shares Out5.612B
10 Day Average Volume18.05M
Dividend1.60
Dividend Yield3.65%
Beta0.68
YTD % Change-25.78

RATIOS/PROFITABILITY

EPS (TTM)5.19
P/E (TTM)8.46
Fwd P/E (NTM)7.66
EBITDA (TTM)42.238B
ROE (TTM)37.84%
Revenue (TTM)101.132B
Gross Margin (TTM)62.21%
Net Margin (TTM)29.44%
Debt To Equity (MRQ)46.19%

EVENTS

Earnings Date11/01/2022
Ex Div Date11/03/2022
Div Amount0.40
Split Date-
Split Factor-

Latest On Pfizer Inc

Pfizer asks FDA to authorize omicron Covid booster shots for kids ages 5 to 115 Hours AgoCNBC.com
Moderna asks FDA to authorize omicron Covid boosters for kids 6- to 11-year-oldsSeptember 23, 2022CNBC.com
Two-Minute Drill: GOOGL, MSFT & PFESeptember 22, 2022CNBC.com
FDA vaccine chief: Omicron-specific Covid boosters for children are weeks awaySeptember 22, 2022CNBC.com
The side effects to expect from your omicron-specific Covid booster shotSeptember 14, 2022CNBC.com

Content From Our Affiliates

Pfizer (NYSE: PFE) and BioNTech Seek FDA Nod For COVID Booster Shot For Children6 Hours AgoTipRanks
Moderna COVID-19 booster shortage causes canceled appointments, WSJ reportsSeptember 23, 2022TipRanks
Cantor Fitzgerald healthcare analysts to hold KOL luncheon panelSeptember 22, 2022TipRanks
Pfizer to supply up to 6 million Paxlovid treatment courses for COVID-19September 22, 2022TipRanks
Cantor Fitzgerald biotech/pharma analysts hold analyst/industry conference callSeptember 21, 2022TipRanks

Profile

Pfizer Inc. is a research-based, global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company manages its commercial operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation &...

Albert Bourla Ph.D.

Chairman of the Board, Chief Executive Officer

David Denton

Executive Vice President, Chief Financial Officer

Aamir Malik

Executive Vice President, Chief Business Innovation Officer

Lidia Fonseca Ph.D.

Executive Vice President, Chief Digital and Technology Officer

Douglas Lankler

Executive Vice President, General Counsel

Address

235 E 42ND ST

New York, NY

10017-5703

United States

https://www.pfizer.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
RHHBY Roche Holding AG	38.62	-0.98	-2.49%
ABBV Abbvie Inc	141.56	-1.49	-1.04%
MRK Merck & Co Inc	86.48	-0.30	-0.35%
NVS Novartis AG	74.67	-1.34	-1.76%
JNJ Johnson & Johnson	165.85	-0.87	-0.52%